Bartell Drugs kicks off flu vaccine program
Bartell Drugs has launched a seasonal flu shot program that offers vaccinations at all of its 64 stores as well as via an off-site flu clinic program serving area businesses and retirement communities.
Pharmacy
London Drugs helps Canadians get immunized
Pharmacists at London Drugs are working with the Canadian Medical Association (CMA) to help educate parents about immunization options as their children head back to school.
Bayer names new North America president for Consumer Care
Veteran health care products executive Natalie Bartner has joined Bayer HealthCare as president of Bayer Consumer Care, North America.
Mylan takes hostile bid to Perrigo stockholders
As promised, Mylan N.V. has proceeded to make formal bid to acquire Perrigo Co. plc in a deal valued at approximately $27 billion. Mylan said Monday that under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.
NCPA to roll out lab test platform for pharmacies
Community pharmacies will be able to offer patients direct access to lab tests and health screenings via a partnership announced by the National Community Pharmacists Association.
Diplomat sells compounding pharmacy operation
Personalized medicine solution provider Restore Health plans to acquire the compounding pharmacy assets of Diplomat Pharmacy Inc. Financial terms of the agreement weren’t disclosed.
Express Scripts announces CEO succession
Next spring, George Paz is slated to retire as chief executive officer of Express Scripts Holding Co. and be succeeded by president Tim Wentworth.
Yasmin generic released by Mylan
Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive.
NACDS, PhRMA help weigh impact of Rx use on Medicaid costs
The National Association of Chain Drug Stores and the Pharmaceutical Research and Manufacturers of America (PhRMA) co-authored a Health Affairs article on research finding that when prescription drugs are taken as directed by a physician, other medical costs are reduced for certain Medicaid benefici
Mylan to make acquisition bid to Perrigo shareholders
Next week, Mylan N.V. plans to make a formal offer directly to the shareholders of Perrigo plc to buy the company. Mylan said Tuesday that it aims to make the bid on Monday, Sept. 14. Under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each
CVS study: Narrow networks aid Rx adherence
Members of drug benefit plans with narrow pharmacy networks show improved medication adherence, according to a new study by the CVS Health Research Institute.
Sandoz launches Zarxio, the nation’s first biosimilar
Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.
Par Pharmaceutical ships AndroGel generic
Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively.
Lannett to buy Kremers Urban for $1.23 billion
Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
Sam’s Club pharmacies to offer diabetes screenings
This month, Sam’s Club pharmacies plan to hold free diabetes screenings for club members and the public. The Walmart warehouse club chain said Wednesday that the screenings, to be offered on Sept.
Sandoz releases generic of Exelon patch in U.S.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.